Back to search

Article

Quantitative single cell heterogeneity profiling of patient derived tumor initiating gliomaspheres reveals unique signatures of drug response and malignancy

2020-01-14

Abstract excerpt

<h4>Background</h4> Glioblastoma is a deadly brain tumor with median patient survival of 14.6 months. At the core of this malignancy are rare, highly heterogenous malignant stem-like tumor initiating cells. Aberrant signaling across the EGFR-PTEN-AKT-mTOR signal transduction pathways are common oncogenic drivers in these cells. Though gene-level clustering has determined the importance of the EGFR signaling pathw...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
418895da-f86b-5e1c-b8ac-91d7420bc1cc
DOI
10.1101/2020.01.14.900506
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Quantitative single cell heterogeneity profiling of patient derived tumor initiating gliomaspheres reveals unique signatures of drug response and malignancyDOI 10.1101/2020.01.14.900506
Select a neighboring publication to make it the new centre.